Hikma pharmaceuticals revenue
WebJul 15, 2024 · Established in 1978 and headquartered in London, Hikma Pharmaceuticals is a multinational pharmaceutical company that manufactures branded and non-branded … WebMar 21, 2024 · The company's largest shareholder is Darhold Ltd., with ownership of 26%. Meanwhile, the second and third largest shareholders, hold 7.2% and 5.0%, of the shares outstanding, respectively.
Hikma pharmaceuticals revenue
Did you know?
WebWebsite: www.hikma.com Headquarters: London, United Kingdom Size: 5001 to 10000 Employees Founded: 1978 Type: Company - Public (HIK) Industry: Biotech & Pharmaceuticals Revenue: $1 to $5 billion (USD) Competitors: Teva Pharmaceuticals, Sandoz International, Perrigo Create Comparison WebFeb 23, 2024 · Hikma Pharmaceuticals press release (OTCPK:HKMPF): FY GAAP EPS of $1.81.; Revenue of $2.52B (-1.2% Y/Y). 2024 Outlook: Injectables revenue growth in the range of 7% to 9%, with core operating ...
WebApr 12, 2024 · Hikma Pharmaceuticals, a UK-listed company with operations in Europe, the Middle East, North Africa and the US, has appointed Riad Mishlawi as its chief executive. ... Hikma said in a filing to the LSE. Revenue for the year was marginally down 1 per cent to $2.5 billion, while operating profit slid 52 per cent to $282 million. ... WebApr 3, 2024 · Hikma Pharmaceuticals earned $1.8bn in revenues from its three generics business segments namely injectables, generics, and branded generics in 2024. The injectables segment recorded revenues of $832m, while the generics segment recorded $692m and branded generics excluding in-licensed products recorded $347m.
WebAug 6, 2024 · The pharmaceutical company reported a 7% rise in revenue for the six months ended June 30, to US$1.21bn, whilst operating profit increased 15% to US$326mln. It generated US$224mln of cashflow from ... WebMar 16, 2024 · For more information visit www.hikma.com. $4.3m 15%. Core results are presented to show the underlying performance of the Group, excluding the exceptional items and other adjustments set out in Note 6 of the Group consolidated financial statements. A reconciliation from core to reported operating profit is included within the consolidated ...
WebOur Branded business supplies branded generics and in-licensed patented products from our local manufacturing facilities to retail and hospital customers across the MENA region. Revenue ($m) 27%of Group revenue (2024: 26%) Generics. Our Generics business …
WebMar 22, 2024 · Hikma Pharmaceuticals Financials Summary financials Revenue ( FY, 2024) $2.5B Gross profit ( FY, 2024) $1.6B Net income ( FY, 2024) $191.0M Cash ( H1, 2024) … ipv statistics 2022WebBy 2009, Hikma was the fifth largest pharmaceutical company in the MENA region, enjoying a 3.7% market share, 12.4% annual growth rate and over US$ 400 million in sales. For the six months ended June 30, 2010, revenue was up 11.3% and operating profit was up by 20.2% on the previous year. ipswich library cardWebAug 7, 2024 · Revenue from Hikma's generic drugs business grew an annual 8 per cent to $400m during the first half of 2024, reflecting good demand for new and recently launched products, a more favourable product mix and lower operating expenses, Hikma said. The company expects generics revenue to be in the range of $810m to $830m for the full year, … ipsos long covid researchWebAug 6, 2024 · Hikma Pharmaceuticals (HKMPF): 1H Non-GAAP EPS of $0.97; GAAP EPS of $1.07.Revenue of $1.21B (+7% Y/Y) beats by $30M.Press Release Hikma … iqms tech notesWebFeb 27, 2024 · London-listed Hikma Pharmaceuticals expects sales growth in 2024 after posting a 10 per cent rise in annual core operating profit for 2024 driven by higher revenue as demand for its injectable drugs grew. The drugmaker's group core operating profit rose to $508 million (Dh1.86 billion) in the year ending December 31, up from $460m in 2024 ... ipswich vs charltonWebApr 3, 2024 · Hikma Pharmaceuticals Usa's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry. Hikma Pharmaceuticals Usa's Annual Report & Profile shows critical firmographic facts: What is the company's size? iptv providers windsor ontarioWebMar 19, 2024 · Hikma Pharmaceuticals ( LON:HIK) Full Year 2024 Results Key Financial Results Revenue: US$2.52b (down 1.4% from FY 2024). Net income: US$188.0m (down … iptwindsor